Bryce Point Capital, LLC
- SEC CIK
- 0002019492
- Latest filing
- Nov 6, 2025
ROIV holding history
Roivant Sciences Ltd. in every 13F filed by Bryce Point Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ROIV overviewAll 13F holders of ROIVFull Q3 2025 holdings
- Shares (Q3 2025)
- 26,506
- Value
- $401.0K
- % of portfolio
- 0.5%
- Quarters held
- 4
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 26,506 | $401.0K | 0.5% | −18,022−40.5% | Reduced | Holders |
| Q2 2025 | 44,528 | $501.8K | 0.4% | −30,739−40.8% | Reduced | Holders |
| Q1 2025 | 75,267 | $789.5K | 0.6% | −21,283−22.0% | Reduced | Holders |
| Q4 2024 | 96,550 | $1.14M | 0.3% | – | No prior filing | Holders |